CareLit Fachartikel

2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors

N.N. · Klinische Pädiatrie · 2017 · Heft 03 · S. 147-167

Dokument
1087360
CareLit-ID
Jahr
2017
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
N.N.
Ausgabe
Heft 03 / 2017
Jahrgang 229
Seiten
147-167
Erschienen: 2017-05-01 00:00:00
ISSN
0300-8630
DOI
10.1055/s-0043-103086

Zusammenfassung

Abstract The clinical course of neuroblastoma is more heterogeneous than any other malignant disease. Most low-risk patients experience regression after limited or even no chemotherapy. However, more than half of high-risk patients die from disease despite intensive multimodal treatment. Precise patient characterization at diagnosis is key for risk-adapted treatment. The guidelines presented here incorporate results from national and international clinical trials to produce recommendations for diagnosing and treating neuroblastoma patients in German hospitals outside of clinical trials.

Schlagworte

neuroblastoma ganglioneuroma childhood cancer treatment recommendations Neuroblastom Ganglioneurom Behandlungsempfehlungen Kind Diagnosis After Klinische Pädiatrie